QUALITY BY DESIGN (QBD) AS A TOOL FOR THE OPTIMIZATION OF INDOMETHACIN FREEZE-DRIED SUBLINGUAL TABLETS: IN VITRO AND IN VIVO EVALUATION

MERVAT SHAFIK IBRAHIM; NIHAL MOHAMED ELMAHDY ELSAYYAD; ABEER SALAMA; SHEREEN H. NOSHI

doi:10.22159/ijap.2021v13i5.42216

Authors

MERVAT SHAFIK IBRAHIM Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Cairo, Egypt
NIHAL MOHAMED ELMAHDY ELSAYYAD Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Cairo, Egypt https://orcid.org/0000-0003-4601-0020
ABEER SALAMA Department of Pharmacology, National Research Centre (NRC), El-Buhouth Street, Cairo, Egypt
SHEREEN H. NOSHI Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Cairo, Egypt

DOI:

https://doi.org/10.22159/ijap.2021v13i5.42216

Keywords:

Quality by Design, Indomethacin, freeze-dried tablet, sublingual tablet, stability testing

Abstract

Objective: This study aims to prepare and optimize indomethacin freeze-dried sublingual tablets (IND-FDST) by utilizing a quality by design (QbD) approach to achieve rapid drug dissolution and simultaneously bypassing the GIT for better patient tolerability.

Methods: A screening study was utilized to determine the most significant factors which the quality attributes, namely disintegration time and % friability. Then an optimization study was conducted using a full response surface design to determine the optimized formula by varying the amount of the matrix-forming polymer (gelatin) and super disintegrant (croscarmellose sodium (CCS)). The variables' effect on the % friability, disintegration time, wetting time, and amount of drug release after 10 min (%Q10) was studied. The optimized formula was tested for compatibility, morphology as well as stability studies under accelerated conditions in addition to the in vivo pharmacodynamics in rats. QbD was adopted by utilizing a screening study to identify the significant formulation factors followed by a response surface optimization study to determine the optimized IND-FDST formulation.

Results: Optimized IND-FDST comprised of gelatin/CCS combination in a ratio of 1:1 possessed adequate %friability (0.73±0.03%), disintegration time (25.40±1.21 seconds), wetting time (3.49±0.68 seconds), and % Q10 (100.99±5.29%) as well as good stability under accelerated conditions. IND-FDST also showed significant inhibition of edema, tumour necrosis factor-alpha, and interleukin-6 release in vivo compared to the oral market product by 70%, 42%, and 65%, respectively.

Conclusion: QbD presents a successful approach in the optimization of a successful IND-FDST formula that showed superior in vivo and in vitro characteristics.

Downloads

Download data is not yet available.

References

Parhi R. Improvement of dissolution rate of indomethacin from fast dissolving tablets. Indones J Pharm 2014;25:198.

Krishnaiah YSR, Karthikeyan RS, Satyanarayana V. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Int J Pharm 2002;241:353–66.

Prabhu P, Malli R, Koland M, Vijaynarayana K, D′Souza U, Harish N, et al. Formulation and evaluation of fast dissolving films of levocitirizine di hydrochloride. Int J Pharm Investig 2011;1:99.

Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000;97:6079–84.

Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol 2019;10:1–9.

Tayel SA, El Nabarawi MA, Amin MM, AbouGhaly MHH. Comparative study between different ready-made orally disintegrating platforms for the formulation of sumatriptan succinate sublingual tablets. AAPS PharmSciTech 2017;18:410–23.

Aboutaleb AE, Abdel Rahman SI, Ahmed MO, Younis MA. Design and evaluation of domperidone sublingual tablets. Int J Pharm Pharm Sci 2016;8:195–201.

Sahoo S, Malviya K, Makwana A, Mohapatra PK, Sahu AR. Formulation, optimizationand evaluation of sublingual film of enalapril maleate using 32 full factorial design. Int J Appl Pharm 2021;13:178–86.

Thayyilakandy S, Gayathri PS, Arjun KK, Krishnakumar G, Nair SC. Fast dissolving sublingual patch of phenobarbital sodium: Formulation and in vitro evaluation. Int J Appl Pharm 2020;12:158–65.

Swapna K, Aparna C, Srinivas P. Formulation and evaluation of montelukast sodium and levocetirizine dihydrochloride sublingual tablets. Asian J Pharm Clin Res 2015;8:171–5.

Abd Elbary A, Ali AA, Aboud HM. Enhanced dissolution of meloxicam from orodispersible tablets prepared by different methods. Bull Fac Pharm Cairo Univ 2012;50:89–97.

Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162–71.

Yir-Erong B, Bayor MT, Ayensu I, Gbedema SY, Boateng JS. Oral thin films as a remedy for noncompliance in pediatric and geriatric patients. Ther Delivery 2019;10:443–64.

Ali BE, Rabba AK, Fayed MH, El-Say KM, Anwer MK, Ansari MJ, et al. Development and optimization of fluoxetine orally disintegrating tablets using box-behnken design. Trop J Pharm Res 2016;15:667–77.

Mahmoud AA, Salah S. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets. Drug Dev Ind Pharm 2012;38:762–9.

Kassem AA, Labib GS. Flash dissolving sublingual almotriptan malate lyotabs for management of migraine. Int J Pharm Pharm Sci 2016;9:125.

Fokunang C. Overview of non-steroidal anti-inflammatory drugs (nsaids) in resource limited countries. MOJ Toxicol 2018;4:5–13.

Patel KM, Biswajit B, Karna N, Patel J. Preparation and evaluation of sustain release indomethacin tablets using skimmed milk and povidone. Int J Curr Pharm Res 2011;3:7–9.

Baber N, Halliday LDC, Van Den Heuvel WJA, Walker RW, Sibeon R, Keenan JP, et al. Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders. Ann Rheum Dis 1979;38:128–36.

Bruckner FE, Randle APH. The use of indomethacin in rheumatoid arthritis. Rheumatology 1965;8:100–2.

Calabro JJ, Londino AVJ, Eyvazzadeh C. Sustained-release indomethacin in the management of the acute painful shoulder from bursitis and/or tendinitis. Am J Med 1985;79:32–8.

Gliszczyńska A, Nowaczyk M. Lipid formulations and bioconjugation strategies for indomethacin therapeutic advances. Molecules 2021;26:1576.

Lichtenberger LM, Romero JJ, Dial EJ. Gastrointestinal safety and therapeutic efficacy of parenterally administered phosphatidylcholine-associated indomethacin in rodent model systems. Br J Pharmacol 2009;157:252–7.

Bjarnason I, Scarpignato C, Holmgren E, Olszewski M, Rainsford KD, Lanas A. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 2018;154:500–14.

Elkady OA, Tadros MI, El-laithy HM. QbD approach for novel crosslinker-free ionotropic gelation of risedronate sodium–chitosan nebulizable microspheres: Optimization and Characterization; 2020.

ICH Q8. EMEA/CHMP, 2009, ICH Topic Q 8 (R2) Pharmaceutical development, Step 5: Note for guidance on pharmaceutical development; 2009. p. 8. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/W C500059258.pdf, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002872.pdf. [Last accessed on 24 Jul 2017]

Mandlik SK, Agarwal PP, Dandgavhal HP. Implementation of quality by design (Qbd) approach in formulation and development of ritonavir pellets using extrusion spheronization method. Int J Appl Pharm 2020;12:139–46.

Malik R, Kumar S, Choudhary N, Choudhary M, Budhwar V. Formulation and evaluation of fast disintegrating tablet of telmisartan. J Chem Pharm Res 2016;8:61–7.

The United States pharmacopeia 39/National Formulary 34, The United States pharmacopeial convention Inc. Rockville, MD; 2016.

El-Laithy HM, Badawi A, Abdelmalak NS, Elsayyad NME. Stabilizing excipients for engineered clopidogrel bisulfate procubosome derived in situ cubosomes for enhanced intestinal dissolution: stability and bioavailability considerations. Eur J Pharm Sci 2019;136:104954.

Singh J, Garg R, Gupta G Das. Enhancement of solubility of lamotrigine by solid dispersion and development of orally disintegrating tablets using 32 full factorial design. J Pharm 2015;2:1–8.

Talluri M, Saha S, Adahalli SB. Development and evaluation of sublingual tablet of zolpidem tartrate an antipsychotic drug. Int J Pharm Pharm Sci 2016;8:179–87.

Javadzadeh Y, Shariati H, Movahhed Danesh E, Nokhodchi A. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm 2009;35:243–51.

Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 1996;20:64–74.

Venkateswarlu K, Thirumalesh Naik SB, Chandrasekhar KB. Formulation and in vitro evaluation of orlistat orodispersible tablets for enhancement of dissolution rate. Int J Pharm Pharm Sci 2016;8:236–41.

Abdel Halim S. Formulation of new sildenafil citrate-caffeine orally disintegrating tablets: in vitro and in vivo evaluation. J Pharm Res Opin 2013;3:46–63.

El-Setouhy DA, Basalious EB, Abdelmalak NS. Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: in vitro/in vivo evaluation. Eur J Pharm Biopharm 2015; 94:386–92.

International Conference on Harmonization, (2003) Q1A(R2): Stability testing of new drug substances and products (second revision), EU: adopted by CPMP; 2003. p. 65717-18.

Elsayyad NME, Salama A, Noshi SH. Concurrent tissue engineering and infection prophylaxis utilising stable dual action amoxicillin loaded scaffolds. J Drug Delivery Sci Technol 2020;58:101788.

Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw. Exp Biol Med 1962;3:544–7.

Abd El-Alim SH, Kassem AA, Basha M, Salama A. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int J Pharm 2019;563:293–303.

El Kady WM, Salama AAA, Desoukey SY, Hagag EG, El-Shenawy SM, El-Shanawany MA. Comparative DNA profiling, botanical identification and biological evaluation of gazania longiscapa DC and gazania rigens L. Bull Fac Pharm Cairo Univ 2015;53:129–45.

Kunes M, Kvetina J, Bures J. Type and distribution of indomethacin-induced lesions in the gastrointestinal tract of rat. Neuro Endocrinol Lett 2009;30:96–100.

Lin HL, Zhang GC, Huang YT, Lin SY. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state. J Pharm Sci 2014;103:2386–95.

Soltani B, Nabipour H, Ahmadi Nasab N. Fabrication, controlled release, and kinetic studies of indomethacin-layered zinc hydroxide nanohybrid and its effect on the viability of HFFF2. J Dispers Sci Technol 2018;39:1200–7.

Stukelj J, Svanback S, Kristl J, Strachan CJ, Yliruusi J. Image-based investigation: biorelevant solubility of α and γ indomethacin. Anal Chem 2019;9:3997–4003.

Singh S, Rao KVR, Venugopal K, Manikandan R. Alteration in dissolution characteristics of gelatin-containing formulations: a review of the problem, test methods, and solutions. Pharm Technol North Am 2002;26:36–58.

Borges AF, Silva C, Coelho JFJ, Simoes S. Oral films: status and future perspectives: I-galenical development and quality attributes. J Controlled Release 2015;206:1–19.

Desai PM, Er PXH, Liew CV, Heng PWS. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach. AAPS PharmSciTech 2014;15:1093–104.

Gugulothu D, Desai P, Pandharipande P, Patravale V. Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate. Drug Dev Ind Pharm 2015;41:398–405.

Hiroyuki I, Nambu N, Tsuneji N. Stability and several physical properties of amorphous and crystalline forms of indomethacin. Chem Pharm Bull 1977;57:364–70.

Pan X, Julian T, Augsburger L. Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry. AAPS PharmSciTech 2006;7:E72-E78.

Amdekar S, Roy P, Singh V, Kumar A, Singh R, Sharma P. Anti-inflammatory activity of lactobacillus on carrageenan-induced paw edema in male wistar rats. Int J Inflam 2012;2012:752015.

Trindade PAK, Giglio FPM, Colombini Ishikiriama BL, Calvo AM, Modena KCS, Ribeiro DA, et al. Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extraction. Int J Oral Maxillofac Surg 2011;40:292–7.